Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug evolution concept in drug design: 1. Hybridization method.

Carmen Lazar1, Alicja Kluczyk, Taira Kiyota

  • 1Biotechnology Research Institute, 6100 Royalmount Avenue, Montreal, Quebec, Canada H4P 2R2.

Journal of Medicinal Chemistry
|December 24, 2004
PubMed
Summary

This study introduces "drug evolution" by hybridizing existing drugs to create diverse chemical libraries. This method significantly increases the probability of discovering new drug candidates with varied therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural Transformation of a BRAF Inhibitor into a Selective PKR Inhibitor.

Journal of medicinal chemistry·2026
Same author

Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV Replication.

Journal of medicinal chemistry·2026
Same author

Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer.

European journal of medicinal chemistry·2026
Same author

BOOST 2.0: Feasibility of Using the Nursing Student Workforce to Increase Activity: A Qualitative Study.

SAGE open nursing·2026
Same author

Discovery of pyrrolopyrimidinone inhibitors of the BCL6-SMRT corepressor interaction.

Bioorganic & medicinal chemistry·2026
Same author

Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors.

Bioorganic & medicinal chemistry letters·2025

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Computational Chemistry

Background:

  • Developing novel drug candidates is challenging.
  • Existing methods for generating chemical libraries have limitations.
  • A new approach,
  • drug evolution
  • is proposed to enhance drug discovery.

Purpose of the Study:

  • To introduce and demonstrate
  • hybridization
  • drug evolution as a method for generating diverse chemical libraries.
  • To assess the potential of hybridized molecules as drug candidates.

Main Methods:

  • The study employed a
  • hybridization
  • strategy, analogous to sexual recombination in biological evolution.

Related Experiment Videos

  • Two distinct drug pairs (benzocaine/metoclopramide and aspirin/cresotamide) were hybridized to generate new molecular entities.
  • The resulting chemical libraries were analyzed for the presence of known drugs, novel drug candidates, and their therapeutic applications.

    • Main Results:

    • Hybridization of benzocaine and metoclopramide yielded 16 molecules, including parent drugs, four known drugs, and two reported active compounds.
    • The generated library showed a high proportion of potential drug candidates, suggesting a high probability of discovering new therapeutics.
    • The hybridized molecules exhibited diverse therapeutic applications (38) and targeted a wide range of molecular targets (25).

    Conclusions:

    • "Hybridization" drug evolution is an effective strategy for creating general chemical libraries with a high likelihood of yielding new drugs or drug candidates.
    • The method's success with different drug pairs (benzocaine/metoclopramide and aspirin/cresotamide) demonstrates its broad applicability.
    • This approach offers a promising avenue for accelerating drug discovery and development across various therapeutic areas.